LamdaGen produces label-free Localized SPR based biosensor for drug discovery and bioprocess monitoring. LightPath monitor proteins and small molecules binding in real-time in label-free format.

Featured

LamdaGen has developed a highly sensitive Diagnostic Cardiac Troponin I (cTnI) assay. The Troponin I assay is based upon LamdaGen’s patented Plasmonic ELISA method known as the Optical Enhancement System™ (OES™).

This ultra-sensitive cTnI Plasmonic ELISA utilizes a sandwich immunoassay-coupled with the company’s Localized Surface Plasmon Resonance (LSPR) technology to precisely quantitate the concentration of cTnI in human whole blood, plasma and serum specimens into the sub-picogram range.

Go to Application Note

LamdaGen SX4 Plasmon

LSPR, Plasmon, Nano structured thin film, FWHM, localized surface Plasmon, LamdaGen SX4 biochip, LSPR biosensor

$LSPR m-value, high sensitivity, glucose index of refraction, SX4 biochip, LSPR biosensor, Refractive Index Unit (RIU), Refractive Index Response, LSPR dose response curve$

LamdaGen’s LightPath™ Systems and Sensors enable characterization of biomolecular, enzymatic and chemical type reactions in real-time

LightPath S4, LSPR, label-free, bench top, Highly sensitive, real-time, kinetic data, biomolecule interaction LamdaGen P8 biosensor, LSPR LamdaGen P-5 diagnostic sensor, IVD, nanostructured LSPR diagnostic, OES, Optical enhancement system, POC diagnostic, Point of care, multiplex IVD , multipanel IVD, diagnostic platform